Journal: bioRxiv
Article Title: MLL1 regulates cytokine-driven cell migration and metastasis
doi: 10.1101/2022.10.18.512715
Figure Lengend Snippet: (a) Conditioned medium was collected from scrambled control cells and added to shMLL1 or scrambled control cells. Conditioned medium from scrambled control cells fully rescued cell migration of shMLL1 cells as seen in (b) trajectories and (c) velocities. n(cells) = 81(Scr. cont.), 81(Scr. Cont.+CM), 89 (shMLL1), 85 (shMLL1+CM); one-way ANOVA (**** p < 0.0001, F (3, 332) = 13.68); two-tailed t-test (**** p(sh - sh+CM) < 0.0001, NS p(SC - sh+CM) = 0.8563, NS p(SC+CM - sh+CM) = 0.4392, NS p(SC - SC+CM) = 0.3979). (d) MLL1-Menin inhibition leads to downregulation of key genes in the IL- 6/JAK/STAT3 signaling pathway assessed via qRT-PCR. MLL1-Menin inhibition by n(wells) = 4(each condition); one-way ANOVA (IL6: **** p < 0.0001, F (2, 9) = 61.73; STAT3: * p = 0.0104, F (2, 9) = 7.905; NFKB1: ** p = 0.0075, F (2, 9) = 8.858; NFKB2: **** p < 0.0001, F (2, 9) = 47.67 ; ACTR2: ** p = 0.0073, F (2, 9) = 8.918). (e) MI-2-2 [n(wells) = 4(each condition); one-way ANOVA (**** p < 0.0001, F (2, 9) = 41.11); two-tailed t-test (** p(0 - 10) = 0.0049, **** p(0 - 30) < 0.0001, ** p(10 - 30) = 0.005)] or (f) MI-503 decreased IL-6 production TNBC cell lines. n(wells) = 4(each condition); two-tailed t-test (** p(MDA-MB-231) = 0.0020, * p(BT-549) = 0.0420, *** p(SUM-149) = 0.0007, ** p(SUM-159) = 0.0030,). (g) Phase contract images of cells treated with MLL1-Menin inhibitor show decreased generation of protrusions. Protrusion generation can be rescued by adding IL-6+IL-8 to cells treated with MLL1-Menin inhibitor, MI-2-2. Scale bar 20 µm. (h) A temporal heatmap of protrusion-related parameters show that the cumulative number of protrusions generated per cell and the maximum length of protrusion generated by a cell were reduced by MLL1-Menin inhibition, which coincided with a decrease in cell migration (mean squared displacement). Each row is one cell, and each block is one condition. (i) A rescue of cell motility was attempted by supplementing cells with IL-6/8 on top of MLL1 inhibition by 10 µM MI-2-2. IL-6/8 supplementation fully rescued cell motility despite continuing inhibition of the MLL1-Menin interaction, evident in (j) velocity and (k) trajectories. n(cells) = 135(Untreat.), 82(IL), 98(MI), 120 (IL+MI); one-way ANOVA (**** p < 0.0001, F (3, 431) = 9.233); two-tailed t-test (**** p(MI – MI+IL) < 0.0001, **** p(Untreat. – MI) < 0.0001, NS p(Untreat. – MI+IL) = 0.2905, NS p(MI+IL – IL) = 0.8257, NS p(Untreat. – IL) = 0.4676). (l) Western blotting on pSTAT3 (downstream of IL-6/8) and Arp2/3 (involved in actin assembly downstream of STAT3) shows inhibition and rescue following MLL1 inhibition and IL-6/8 supplementation, respectively. (m) Quantification of four biological repeats of IL- 6/8 rescue western blots emphasize that pSTAT3 and Arp3 levels are significantly reduced and subsequently restored. n(western blots) = 4 (biological replicates); paired two-tailed t-test (** p(pSTAT3) = 0.0056, ** p(Arp3) = 0.0098). (n) STAT3 knockdown reduces cell migration to levels observed with MLL1-Menin inhibition. n(cells) = 110(Scr. cont.), 121(shSTAT3), 121(MI-2-2); one-way ANOVA (**** p < 0.0001, F (2, 349) = 28.75); two-tailed t-test (**** p(SC – shSTAT3) < 0.0001, NS p(shSTAT3 – MI-2-2) = 0.6118, **** p(SC – MI-2-2) < 0.0001). (o) Motility rescued via IL-6/8 supplementation was lost by inhibiting STAT3 (using S3I-201), which lies downstream of IL-6/8. n(cells) = 146(Untreat.), 134(MI), 146 (S3I), 107(MI+IL), 147(MI+IL+S3I); one-way ANOVA (**** p < 0.0001, F (4, 675) = 30.68); two-tailed t-test (**** p(Untreat. - MI) < 0.0001, **** p(MI – MI+IL) < 0.0001, **** p(MI+IL – MI+IL+S3I) < 0.0001, NS p(Untreat. – MI+IL) = 0.9059, NS p(S3I - MI+IL+S3I) = 0.0535). (p) Schematic illustration of MLL1-Menin-based regulation of cell migration. MLL1-Menin interaction controls the production of IL-6, which binds to the IL-6 receptor and leads to phosphorylation of STAT3. pSTAT3 drives actin filament assembly via Arp2/3. Data in this figure was generated with MDA-MB-231 cells embedded in 3D collagen gels except panel f (MDA-MB-231, BT549, SUM-149, and SUM-159).
Article Snippet: Primary antibodies were purchased from Cell Signaling technology (β-Actin-HRP #5125, GAPDH #5174, MLL1 Carboxy-terminal Antigen #14197, Menin #6891, Phospho-Stat3 (Tyr705) #9145, ARP3 #4738, Phospho-Myosin Light Chain 2 (Ser19) #3671, Phospho-Myosin Light Chain 2 (Thr18/Ser19) #3674, Tri-Methyl-Histone H3 (Lys4) #9751, ROCK1 #4035, ROCK2 #8236, NF-κB p65 #8242, and NF-κB1 p105/p50 #3035), or Novus Bio (Gli-2, #NB600) and used at manufacturer’s recommended concentration for western blotting.
Techniques: Migration, Two Tailed Test, Inhibition, Quantitative RT-PCR, Generated, Blocking Assay, Western Blot